60 Degrees Pharmaceuticals (SXTP) Invested Capital (2022 - 2025)
Historic Invested Capital for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to $5.2 million.
- 60 Degrees Pharmaceuticals' Invested Capital fell 2063.45% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 2063.45%. This contributed to the annual value of $4.7 million for FY2024, which is 3418.01% down from last year.
- According to the latest figures from Q3 2025, 60 Degrees Pharmaceuticals' Invested Capital is $5.2 million, which was down 2063.45% from $3.1 million recorded in Q2 2025.
- 60 Degrees Pharmaceuticals' Invested Capital's 5-year high stood at $8.7 million during Q3 2023, with a 5-year trough of -$22.7 million in Q4 2022.
- Its 4-year average for Invested Capital is -$2.7 million, with a median of $4.1 million in 2024.
- In the last 5 years, 60 Degrees Pharmaceuticals' Invested Capital soared by 40064.79% in 2024 and then tumbled by 3935.31% in 2025.
- 60 Degrees Pharmaceuticals' Invested Capital (Quarter) stood at -$22.7 million in 2022, then skyrocketed by 131.36% to $7.1 million in 2023, then crashed by 34.18% to $4.7 million in 2024, then rose by 11.78% to $5.2 million in 2025.
- Its last three reported values are $5.2 million in Q3 2025, $3.1 million for Q2 2025, and $4.7 million during Q1 2025.